ClearPoint Neuro Inc (NAS:CLPT)
$ 11.12 0 (0%) Market Cap: 306.86 Mil Enterprise Value: 288.64 Mil PE Ratio: 0 PB Ratio: 9.50 GF Score: 73/100

Clearpoint Neuro Inc at UBS Global Healthcare Virtual Conference Transcript

May 26, 2021 / 04:00PM GMT
Release Date Price: $17.85 (-1.49%)
Matthew Charles Taylor
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices

Great. Thanks, everybody, for joining us for the next session here in the med tech track of the UBS global financial -- sorry, global healthcare conference. I'm not a financial analyst, I cover med tech actually. So next session is with management from ClearPoint Neuro, and I'm really pleased to be joined by Joe Burnett, the President and CEO. And then we'll have for air cover in the background, Danilo DâAlessandro, the CFO, to help answer any questions if there are ones that, for some reason, Joe can't get to. But first, guys, I just want to say thank you so much for joining us today, and welcome to the presentation.

Joseph Michael Burnett;Matthew Charles Taylor
ClearPoint Neuro, Inc. - President, CEO & Director;UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies

Terrific. Thanks, Matt. And Danilo's name just rolls right off your tongue there. That was very well done.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot